SEC Form 4 · accession 0001437749-15-001050
HYPERION THERAPEUTICS INC · HPTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christine A Nash
Officer — SVP & Chief Commercial Officer
Period of report
Jan 20, 2015
Accepted (ET)
Jan 22, 2015 · 6:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 20, 2015 | S | 2,500 | $24.36 | D | 31,403 | D | |
| Common Stock | Jan 20, 2015 | S | 2,500 | $25.27 | D | 28,903 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 15, 2014.